Inventor · disambiguated record
Suresh K. Tipparaju
Also filed as: TIPPARAJU SURESH K · TIPPARAJU SURESH KUMAR
10 granted patents·8 pending applications·13 citations·filing 2017–2024
86Inventor score
Files withAKAGERA MEDICINES INC6TAKEDA PHARMACEUTICALS CO6CELATOR PHARMACEUTICALS INC4MERRIMACK PHARMACEUTICALS INC2
Top patents by PatentIndex Score
18 records- 0196US11566023B2Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereofAKAGERA MEDICINES INC·Filed 2022·Granted Jan 31, 2023·3 cites·20 claims
- 0296US11555033B2Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereofAKAGERA MEDICINES INC·Filed 2021·Granted Jan 17, 2023·4 cites·26 claims
- 0391US10570119B2Inhibiting ataxia telangiectasia and Rad3-related protein (ATR)MERRIMACK PHARMACEUTICALS INC·Filed 2017·Granted Feb 25, 2020·4 cites·15 claims
- 0488US11787781B2Inhibiting ataxia telangiectasia and RAD3-related protein (ATR)CELATOR PHARMACEUTICALS INC·Filed 2021·Granted Oct 17, 2023·1 cites·20 claims
- 0587US12377078B2Viral inhibitors, the synthesis thereof, and intermediates theretoTAKEDA PHARMACEUTICALS CO·Filed 2024·Granted Aug 5, 2025·0 cites·26 claims
- 0687US12295941B2Viral inhibitors, the synthesis thereof, and intermediates theretoTAKEDA PHARMACEUTICALS CO·Filed 2024·Granted May 13, 2025·0 cites·20 claims
- 0787US12295940B2Viral inhibitors, the synthesis thereof, and intermediates theretoTAKEDA PHARMACEUTICALS CO·Filed 2024·Granted May 13, 2025·0 cites·20 claims
- 0887US2024425495A1Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereofAKAGERA MEDICINES INC·Filed 2024·Application pending·0 cites
- 0987US2024425494A1Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereofAKAGERA MEDICINES INC·Filed 2024·Application pending·0 cites
- 1086US2025333396A1Inhibiting ataxia telangiectasia and rad3-related protein (atr)CELATOR PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1184US2024189286A1Viral inhibitors, the synthesis thereof, and intermediates theretoTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1283US12145928B2Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereofAKAGERA MEDICINES INC·Filed 2022·Granted Nov 19, 2024·0 cites·15 claims
- 1383US11028076B2Inhibiting ataxia telangiectasia and Rad3-related protein (ATR)CELATOR PHARMACEUTICALS INC·Filed 2020·Granted Jun 8, 2021·1 cites·20 claims
- 1483US2024277748A1Viral inhibitors, the synthesis thereof, and intermediates theretoTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1582US12116361B2Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereofAKAGERA MEDICINES INC·Filed 2022·Granted Oct 15, 2024·0 cites·10 claims
- 1682US2023416236A1Inhibiting ataxia telangiectasia and rad3-related protein (atr)CELATOR PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1752US2023167132A1Forms and compositions of inhibitors of plasma kallikreinTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1840US2018021294A1Ephrin Receptor A2 (EPHA2)-Targeted Docetaxel-Generating Nano-Liposome CompositionsMERRIMACK PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Suresh K. Tipparaju files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →